<![CDATA[Iconovo+Lonza: intranasal GLP-1 significant progress]]>Fortsat lang vej igen, men...

https://storage.mfn.se/0eb9a8cd-8ad7-4aac-a59d-90bab061605a/iconovos-development-of-intranasal-glp-1-for-a-more-convenient-treatment-of-obesity-is-making-significant-progress.pdf

Link Preview Image
ICOone®​ Nasal - Iconovo

ICOone® Nasal is intuitive for easy nasal use with high dose, up to 50 mg per unit. Ultra-low cost manufacturing. Is also optional as two cavities design.

favicon

Iconovo (www.iconovo.se)

]]>https://dev.proinvestor.com/forum/topic/447353/iconovolonza-intranasal-glp-1-significant-progressRSS for NodeSat, 13 Jun 2026 02:04:43 GMTWed, 11 Jun 2025 09:50:17 GMT60<![CDATA[Reply to Iconovo+Lonza: intranasal GLP-1 significant progress on Wed, 11 Jun 2025 16:48:44 GMT]]>Intranasal GLP-1? Det har jeg umiddelbart meget lidt tiltro til.

"Data shows impressive and consistent capabilities
suitable for nasal inhalation."

Jeg havde valgt at inkludere de data i min pressemeddelelse, hvis jeg ville overbevise skeptikere og andre.

]]>https://dev.proinvestor.com/forum/post/9493210https://dev.proinvestor.com/forum/post/9493210Wed, 11 Jun 2025 16:48:44 GMT